| (210) | Number of the EPO application | 18724690 |
| (220) | Filing date of the EPO application | 2018.04.27 |
| (80) | EPO patent specification publication (B) | EPB nr. 52/2023, 2023.12.27 |
| (110) | EPO patent number | 3615066 |
| (21) | Number of the application | e 2020 0228 |
| (71) | Name(s) of applicant(s), code of the country | Amgen Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | BRYCH Stephen Robert, US;
WONG Lyanne M., US;
FALLON Jaymille, US;
GOSS Monica Michelle, US;
GU Jian Hua, US;
GHATTYVENKATAKRISHNA Pavan K., US; |
| (73) | Name(s) of owner(s), code of the country | AMGEN Inc., US; |
| (54) | Title of the invention | FORMULATIONS OF HUMAN ANTI-RANKL ANTIBODIES, AND METHODS OF USING THE SAME |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 39/395 (2006.01.01); C07K 16/28 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.04.30 |
| (30) | Priority | 201762492056 P, 2017.04.28, US |
| (86) | International application | PCT/US2018/029728, 2018.04.27 |
| (87) | International publication | WO 2018/200918, 2018.11.01 |